Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  219.01
+2.53 (1.17%)
AAPL  262.55
+0.31 (0.12%)
AMD  240.23
-0.33 (-0.14%)
BAC  51.98
-0.06 (-0.12%)
GOOG  254.07
-2.95 (-1.15%)
META  734.71
+2.54 (0.35%)
MSFT  517.85
+1.06 (0.21%)
NVDA  181.98
-0.66 (-0.36%)
ORCL  277.62
+0.44 (0.16%)
TSLA  445.60
-1.83 (-0.41%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.